Press Announcements > FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

Press Announcements > FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales



FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.  Companies who fail to correct the violations, as outlined in the warning letters, may be subject to enforcement action, including product seizure or injunction. Continue reading...